Hypercube, 1 Ul. Malevicha, Skolkovo Innovation Centre
19 October 2016
Register
On October 19, 2016 at the Hypercube (Skolkovo Innovation Center), representatives of Russian and French business and science will discuss the prospects for mutually beneficial cooperation development in the sphere of biopharmaceutics and biomedicine. The event is being held within the framework of the 50th anniversary of scientific and technical cooperation between the two countries.
The biotechnology market is one of the most dynamically developing and attractive for business. France has been a recognized leader in this field for a long period. Russia, thanks to recent governmental initiatives, is making the first serious steps in this direction and will position itself as one of the key players in the near future. In this period, which is important for the Russian pharmaceutical industry development, joint projects in the sphere of scientific research and creation of new medicines open enormous opportunities for French-Russian cooperation.
The drastic development of the Russian pharmaceutical industry is accompanied by the emerging of many companies and investment institutes in the biotechnology sphere. For commercially successful products to be created as a result of these ventures, Russian developers will need to benefit from the experience and support of their European colleagues. Joint investment scientific and technological projects are one of the key elements of progress and open new opportunities for the creation of innovation projects.
France’s experience in the sphere of promoting projects from the development stage to product commercialization will be extremely useful for young developing companies working in the sphere of biotechnologies, and may become a springboard for their entrance to the global market.
Key objectives of the conference:
• Review of possibilities for a mutually beneficial strategic partnership between Russia and France.
• Highlighting the key aspects of successful entering the global market for Russian companies. Creation of new business contacts between startups, investors, pharmaceutical companies and research centres in the sphere of biotech innovations.
Contact information:Mikhail Smirnov, +7 (495) 956 00 33 (ext. 2076), 8-985-770-86-57, msmirnov@sk.ruVera Bunina, international projects coordinator, +7 (495) 956 00 33 (ext. 2402), 8-910-494-96-18, VBunina@sk.ru
Skolkovo Foundation is a non-profit organization founded in September 2010 by the Russian government with the objective of accelerating Russia’s transformation from a resource-intensive to an innovation-based economy. To achieve this objective, the Foundation is overseeing the creation of the Skolkovo Innovation Center, composed of more than 1,500 high-tech startups, Skolkovo Technopark, the Skolkovo Institute of Technology (Skoltech) - a new graduate research University established in collaboration with the Massachusetts Institute of Technology - and Skolkovo city, located near Moscow. Together, these entities establish a vibrant ecosystem of technology innovation and entrepreneurship. The cumulative revenue of Skolkovo’s startups through June 2016 reached $1.6 billion. They brought in more than $350 million in investment, creating 21,800 jobs and filing over 1,900 patent applications along the way. By 2020 over 2 million square meters of residential and office space will be built in Skolkovo with 35,000 people working daily in the Innovation Center. For more information: http://www.sk.ru/en
Media contact:
Alexandra Barschevskaya Press secretarySkolkovo FoundationTel.: +7 (495) 956 00 33, ext. 2657E-mail: ab@sk.ru